EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives

Binwei Jin, Zhiming Zhang, Yang Zhang, Minjun Yang, Cheng Wang, Jiayi Xu, Yu Zhu, Yafei Mi, Jianjun Jiang, Zhenzhu Sun

Frontiers in Pharmacology · 01.10.2024 · 15

DOI: 10.3389/fphar.2024.1482986 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.10.2024. Verfasst von Binwei Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia-reperfusion injury (MIRI) is a significant factor in the development of cardiac dysfunction following a myocardial infarction. Ferroptosis, a type of regulated cell death driven by iron and marked by lipid peroxidation, has garnered growing interest for its crucial involvement in the pathogenesis of MIRI.This review comprehensively examines the mechanisms of ferroptosis, focusing on its regulation through iron metabolism, lipid peroxidation, VDAC signaling, and antioxidant system dysregulation. We also compare ferroptosis with other forms of cell death to highlight its distinct characteristics. Furthermore, the involvement of ferroptosis in MIRI is examined with a focus on recent discoveries concerning ROS generation, mitochondrial impairment, autophagic processes, ER stress, and non-coding RNA regulation. Lastly, emerging therapeutic strategies that inhibit ferroptosis to mitigate MIRI are reviewed, providing new insights into potential clinical applications.

Schlagwörter

Stichwörter der Autor:innen

ferroptosisiron metabolismlipid peroxidationmyocardial ischemia-reperfusion injuryreactive oxygen speciestherapeutic strategies

Autor:innen und Institutionen

  • Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Laboratory of Cardiovascular Disease, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
  • Department of Cardiology, Taizhou hospital of Zhejiang Province, Shaoxing University, Linhai, China.
  • Medical Research Center, Taizhou Hospital of Zhejiang Province, Linhai, China.

Zitieren

APA

Jin, B., Zhang, Z., Zhang, Y., Yang, M., Wang, C., Xu, J., Zhu, Y., Mi, Y., Jiang, J., & Sun, Z. (2024). Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1482986

Vancouver

Jin B, Zhang Z, Zhang Y, Yang M, Wang C, Xu J, et al. Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1482986

BibTeX
@article{Jin2024,
  author = {Jin, Binwei and Zhang, Zhiming and Zhang, Yang and Yang, Minjun and Wang, Cheng and Xu, Jiayi and Zhu, Yu and Mi, Yafei and Jiang, Jianjun and Sun, Zhenzhu},
  title = {Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1482986}
}
Kostenlos starten →